Early Rhythm Control Effective in Atrial Fibrillation Patients Regardless of Diabetes or Obesity Status: Study Shows
Germany: A secondary analysis of the EAST-AFNET 4 randomized clinical trial, published in JAMA Cardiology, has highlighted that early rhythm control therapy remains effective and safe in patients with atrial fibrillation (AF) irrespective of the presence of obesity or diabetes. The study was conducted by Andreas Metzner and colleagues from the German Center for Cardiovascular […]